Drug Discovery World
DECEMBER 28, 2022
Gyrolab Human Cytokine Kit Reagents are the first in a range of new biomarker kits from Gyros Protein Technologies. . They include five single analyte biomarker kit reagents for the quantification of human inflammatory cytokines: human TNF-a, IFN-gamma, IL-6, IL-10 and IL-4. . Gyrolab Biomarker Kits – Gyros Protein Technologies .
FDA Law Blog
AUGUST 3, 2022
If anything, the announcement was remarkably inconspicuous: a seemingly throwaway sentence in a draft compliance policy guide for research use only and investigational use only products. At the same time, FDA’s basic operational stance hasn’t changed much either.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
AUGUST 23, 2023
Asks Matt Clifford , Director, Research and Innovation Strategy, IDBS. Research team leaders are being asked to find more and better drug targets and to take on more projects throughout the research and development process. In this metaphor, that’s the regulatory, compliance goals of data management achieved.
XTalks
OCTOBER 19, 2023
They typically work in the biotechnology, pharmaceutical and diagnostic sectors as well as in academic research, having pivotal roles in the early stages of drug discovery, research and diagnostic tool development by creating reliable tests that can provide essential data on biological samples.
Drug Discovery World
JANUARY 30, 2024
Lentivirus strategies are one of the most widely used tools in biomedical research and clinical testing, says Stella Vnook, CEO, Likarda. “Dr High-cost materials: Specialised equipment, reagents, and cell culture media significantly contribute to the overall cost. Automating and scaling up manufacturing is crucial for cost reduction.
Advarra
NOVEMBER 29, 2022
The field of cell and gene therapies (CGT) is constantly evolving, and there has been significant progress in this area of research. Dealing with confusing regulatory guidelines is one of the top obstacles researchers face as they develop CGT products 1. Recent Problems in Cell and Gene Therapy Development.
Drug Discovery World
FEBRUARY 27, 2023
The system features high-throughput fast dual detectors, enabling researchers to screen millions of samples with the increased accuracy, speed and sensitivity. This enables researchers to perform a wide range of assays for different applications within one instrument.
Expert insights. Personalized for you.
97 
Let's personalize your content